The annual meeting of the AAN is attended by more than 15,000 neurologists and neuroscientists from the US and abroad. The American Academy of Neurology has formal policies for avoiding
conflicts of interest with pharmaceutical and device industries, and meets or exceeds all recommendations of the Council of Medical Specialty Societies Code. The journal,
Neurology, is the official journal of the AAN. It is a peer-reviewed medical journal which is also referred to colloquially as the "Green Journal" and is published by
Wolters-Kluwer. The AAN publishes the bimonthly magazine
Brain&Life. It also awards, in association with the American Brain Foundation, the
Potamkin Prize. Launched in 2003, Neurology on the Hill is an annual event in Washington, D.C., during which neurologists meet with members of congress to advocate on behalf of policies and legislation that have a direct impact on the delivery of neurological care. ===Top five
Choosing Wisely recommendations=== The AAN partnered with the
American Board of Internal Medicine Foundation and
Consumer Reports to provide their top 5 recommendations for neurologists. Out of 178 nominations from AAN members, these 5 guidelines were selected by a panel of 4 AAN Staff and 10 experienced AAN members who voted according to a modified
Delphi method. The guidelines were published in
Neurology on February 20, 2013. • Don't perform
EEGs for headaches. • Don't perform imaging of the carotid arteries for simple
syncope without other neurologic symptoms. • Don't use
opioid or
butalbital treatment for migraine except as a last resort. • Don't prescribe
interferon-beta or
glatiramer acetate to patients with disability from progressive, non-relapsing forms of
multiple sclerosis. • Disrecommend for
asymptomatic carotid stenosis unless the complication rate is low (<3%). ==See also==